Healthy Clinical Trial
— GLUCAMOfficial title:
An Explorative Study to Characterize the Glycaemic and Insulinaemic Responses of Regular Camel Milk and Camel Milk Powder
Rationale: Recently, human, animal and epidemiological studies suggested that camel milk has
a hypoglycaemic activity. However, a mechanism and reasons for this activity have not been
sufficiently studied. Therefore, a study on a glycaemic and insulinaemic responses of
regular camel milk and camel milk powder is needed.
Objective: To explore the glycaemic and insulinaemic responses of regular camel milk and
camel milk powder in healthy adults.
Study design: In a randomised, single-blind and cross over design, two hour post prandial
glucose and insulin responses of 4 treatments (regular camel milk, camel milk powder,
regular cow milk and glucose) will be measured . Those treatments will be consumed in a
portion that contained 25g available carbohydrate. Finger-prick capillary blood samples will
be taken at fasting, and 15, 30, 45, 60, 90, 120 minutes after ingestion of the test
product. Venepunctures will be taken at fasting, 30 and 75 minutes after ingestion of the
test product. The measurements will be conducted on 4 separate days with at least 2 days
wash out.
Study population: 20 healthy volunteers aged 18 to 35 years, with BMI between 18.5 to 25
kg/m2.
Intervention: The treatments are regular camel milk, camel milk powder, regular cow milk and
glucose. These are standardized to 600ml containing 25g available carbohydrate.
Main study parameters/endpoints: Main parameters are postprandial blood glucose and insulin
responses. Secondary parameters: amino acid composition and glycemic index.
Nature and extent of the burden and risks associated with participation, benefit and group
relatedness: This intervention is non-therapeutic to the subjects. The risk associated with
participation is negligible and the burden can be considered low. Before subjects are able
to participate in this study they will have to fill out a brief questionnaire, and have
their fasting blood glucose measured, in order to ensure they fit the inclusion criteria of
the study. Once entering the study, each subject will have to visit the research centre 4
times for the postprandial tests. On each measurement day, each subject will be required to
have fasted for at least ten hours before (an overnight fast). Each subject will have 7
finger-prick blood samples and 3 venapunctures taken during each visit. A maximum amount of
50 ml blood is drawn per day.
| Status | Completed |
| Enrollment | 20 |
| Est. completion date | February 2012 |
| Est. primary completion date | February 2012 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Both |
| Age group | 18 Years to 35 Years |
| Eligibility |
Inclusion Criteria: - Healthy: as judged by the subjects; - Age: 18 to 35. Exclusion Criteria: - Pregnant or lactating females; - Presence of a chronic disease such as diabetes, illness, dysmetabolic syndrome; - 18.5 > BMI > 25 kg/m2; - Lactose intolerance or experiencing discomfort after milk consumption; - Weight loss or gain of more than 5 kg in the last two months; - Using an energy restricted diet during the last 2 months; - Fasting blood glucose levels >100 mg/dl or 5.6 mmol/l (18); - Smokers; - Use of medications other than birth control, paracetamol, aspirin, asthma or hay fever; - Previous problems with blood sampling. |
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science
| Country | Name | City | State |
|---|---|---|---|
| Netherlands | Wageningen University | Wageningen | Gelderland |
| Lead Sponsor | Collaborator |
|---|---|
| Wageningen University |
Netherlands,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | blood glucose and insuline concentrations | During the test session, subjects will drink raw camel milk, camel milk powder solution, raw cow milk and glucose solution. At time points 0, 15, 30, 45, 60, 90 and 120 minutes blood glucose level will be measured by finger-prick blood samples. Also, at time points 0, 30, 75 minutes insulin level will be measured by venepuncture blood samples. | 2 months | No |
| Secondary | Blood amino acids concentration | During the test session, subjects will drink raw camel milk, camel milk powder solution, raw cow milk and glucose solution. At time points 0, 30, 75 minutes blood amino acids level will be measured by venepuncture blood samples. | 2 months | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
| Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
| Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
| Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
| Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
| Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
| Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
| Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
| Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
| Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
| Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
| Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
| Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
| Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
| Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
| Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
| Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |